Zobrazeno 1 - 10
of 32
pro vyhledávání: '"Zhao, Qing‐Meng"'
Publikováno v:
In Chemical Engineering Journal 1 February 2024 481
Autor:
Li, Jia‐Qi1 (AUTHOR), Zhao, Qing‐Meng1 (AUTHOR), Zhou, Yong‐Dong1 (AUTHOR), Zhao, Zong‐Yan1 (AUTHOR) zzy@kust.edu.cn
Publikováno v:
Journal of the American Ceramic Society. May2023, Vol. 106 Issue 5, p3009-3023. 15p. 1 Color Photograph, 12 Graphs.
Autor:
Li-ying Jia, Gui-yun Cao, Jia Li, Lu Gan, Jin-xin Li, Xin-yi Lan, Zhao-qing Meng, Xin He, Chun-feng Zhang, Chong-Zhi Wang, Chun-Su Yuan
Publikováno v:
Frontiers in Pharmacology, Vol 12 (2021)
SheXiang XinTongNing (XTN), which is composed of six traditional Chinese herbs, is a commercially available Chinese patent medicine that has been widely used as the treatment of coronary heart disease (CHD). Its mechanisms against coronary heart dise
Externí odkaz:
https://doaj.org/article/591aeb8a341a4d79b1d3d948f5a00afb
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Jin-xin Li, Xin-Yi Lan, Chun-Feng Zhang, Lu Gan, Xiao-Fan Zhang, Gui-yun Cao, Chao-lin Yang, Jia Li, Zhao-qing Meng
Publikováno v:
The American Journal of Chinese Medicine. 48:107-126
The Chinese patent medicine She-Xiang-Xin-Tong-Ning (SXXTN) is a clinical medication for coronary heart disease (CHD) and angina pectoris. This study aimed to investigate pharmacological effects of SXXTN and elucidate the role in angiogenesis on huma
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::1e33101832ca3d62a444634adfdd6350
https://doi.org/10.1142/s0192415x20500068
https://doi.org/10.1142/s0192415x20500068
Publikováno v:
Pakistan journal of pharmaceutical sciences. 35(1)
This study is aimed to investigate the effect of Xilingjiedu capsule (XLC), one of a preparation of traditional Chinese medicine, on influenza A (H1N1) virus as well as its preliminary mechanism. The median cell mortality (TC
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::9399cb28f00f75fff51db94f2cf0749c
https://pubmed.ncbi.nlm.nih.gov/35221280
https://pubmed.ncbi.nlm.nih.gov/35221280
Autor:
Li-Li, Zhu, Gui-Yun, Cao, Li-Ying, Jia, Guo, Zheng, Liang, Zhang, Ping, Sheng, Zhao-Qing, Meng, Xin, He, Chun-Feng, Zhang, Chong-Zhi, Wang, Chun-Su, Yuan
Publikováno v:
Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease. 1868:166539
Muscone is the main active compound of Moschus. In this paper, the cardioprotective effect of Muscone on acute myocardial ischemia (AMI) rats and its potential mechanisms were investigated. AMI rat models were established to evaluate the protective e
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6d90d428c071db2ed3225ef90ca40dbe
https://doi.org/10.1016/j.bbadis.2022.166539
https://doi.org/10.1016/j.bbadis.2022.166539
Autor:
Zhao-qing Meng, Gui-yun Cao, Jin-xin Li, Chun-Su Yuan, Xin-Yi Lan, Chun-Feng Zhang, Li-ying Jia, Lu Gan, Chong-Zhi Wang, Jia Li, Xin He
Publikováno v:
Frontiers in Pharmacology, Vol 12 (2021)
Frontiers in Pharmacology
Frontiers in Pharmacology
SheXiang XinTongNing (XTN), which is composed of six traditional Chinese herbs, is a commercially available Chinese patent medicine that has been widely used as the treatment of coronary heart disease (CHD). Its mechanisms against coronary heart dise
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c983eabdfe7f7c337d5256590163439c
https://www.frontiersin.org/articles/10.3389/fphar.2021.698981/full
https://www.frontiersin.org/articles/10.3389/fphar.2021.698981/full
Publikováno v:
Journal of separation scienceREFERENCES. 44(9)
Fufang Xiling Jiedu capsule is an effective Chinese medicine widely used for the treatment of cold and influenza. However, its chemical constituents had not been determined, which entailed a huge obstacle to further pharmacological studies, clinical-
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::12cb2cd2ef8c35296d5435fa360a5d1e
https://pubmed.ncbi.nlm.nih.gov/33576573
https://pubmed.ncbi.nlm.nih.gov/33576573
Autor:
Li-ying Jia, Xin-Yi Lan, Chao-lin Yang, Jia Li, Jin-xin Li, Gui-yun Cao, Chun-Feng Zhang, Lu Gan, Zhao-qing Meng
Background SheXiang XinTongNing, a commercially available Chinese patent medicine, has been widely used in the treatment of coronary heart disease. However, the mechanisms of SheXiang XinTongNing are still unclear. The aim of this study was to invest
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::896f057d767a1bcac7f825014a7b5403
https://doi.org/10.21203/rs.3.rs-21814/v1
https://doi.org/10.21203/rs.3.rs-21814/v1
